112 related articles for article (PubMed ID: 36858579)
21. Autologous melanoma vaccine induces antitumor and self-reactive immune responses that affect patient survival and depend on MHC class II expression on vaccine cells.
Lotem M; Machlenkin A; Hamburger T; Nissan A; Kadouri L; Frankenburg S; Gimmon Z; Elias O; David IB; Kuznetz A; Shiloni E; Peretz T
Clin Cancer Res; 2009 Aug; 15(15):4968-77. PubMed ID: 19602547
[TBL] [Abstract][Full Text] [Related]
22. Administration of sulfosuccinimidyl-4-[N-maleimidomethyl] cyclohexane-1-carboxylate conjugated GP100(25-33) peptide-coupled spleen cells effectively mounts antigen-specific immune response against mouse melanoma.
Chang X; Xia CQ
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):46-52. PubMed ID: 26545782
[TBL] [Abstract][Full Text] [Related]
23. Lipid-enveloped zinc phosphate hybrid nanoparticles for codelivery of H-2K(b) and H-2D(b)-restricted antigenic peptides and monophosphoryl lipid A to induce antitumor immunity against melanoma.
Zhuang X; Wu T; Zhao Y; Hu X; Bao Y; Guo Y; Song Q; Li G; Tan S; Zhang Z
J Control Release; 2016 Apr; 228():26-37. PubMed ID: 26921522
[TBL] [Abstract][Full Text] [Related]
24. Synergism between CpG-containing oligodeoxynucleotides and IL-2 causes dramatic enhancement of vaccine-elicited CD8+ T cell responses.
Kochenderfer JN; Chien CD; Simpson JL; Gress RE
J Immunol; 2006 Dec; 177(12):8860-73. PubMed ID: 17142789
[TBL] [Abstract][Full Text] [Related]
25. Tumor cell membrane enveloped aluminum phosphate nanoparticles for enhanced cancer vaccination.
Gan J; Du G; He C; Jiang M; Mou X; Xue J; Sun X
J Control Release; 2020 Oct; 326():297-309. PubMed ID: 32659330
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of cancer vaccine settings for the selection of an effective protocol in mice.
Kalli F; Machiorlatti R; Battaglia F; Parodi A; Conteduca G; Ferrera F; Proietti M; Tardito S; Sanguineti M; Millo E; Fenoglio D; De Palma R; Inghirami G; Filaci G
J Transl Med; 2013 May; 11():120. PubMed ID: 23663506
[TBL] [Abstract][Full Text] [Related]
27. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for positively charged drugs.
Takeuchi I; Takeshita T; Suzuki T; Makino K
Colloids Surf B Biointerfaces; 2017 Dec; 160():520-526. PubMed ID: 29017147
[TBL] [Abstract][Full Text] [Related]
28. CpG-ODN-stimulated dendritic cells act as a potent adjuvant for E7 protein delivery to induce antigen-specific antitumour immunity in a HPV 16 E7-associated animal tumour model.
Kim TG; Kim CH; Won EH; Bae SM; Ahn WS; Park JB; Sin JI
Immunology; 2004 May; 112(1):117-25. PubMed ID: 15096191
[TBL] [Abstract][Full Text] [Related]
29. Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomes.
Li WM; Dragowska WH; Bally MB; Schutze-Redelmeier MP
Vaccine; 2003 Jul; 21(23):3319-29. PubMed ID: 12804863
[TBL] [Abstract][Full Text] [Related]
30. Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696).
Schaefer C; Butterfield LH; Lee S; Kim GG; Visus C; Albers A; Kirkwood JM; Whiteside TL
Int J Cancer; 2012 Aug; 131(4):874-84. PubMed ID: 22021080
[TBL] [Abstract][Full Text] [Related]
31. Production, purification, and in vivo evaluation of a novel multiepitope peptide vaccine consisted of immunodominant epitopes of SYCP1 and ACRBP antigens as a prophylactic melanoma vaccine.
Safavi A; Kefayat A; Sotoodehnejadnematalahi F; Salehi M; Modarressi MH
Int Immunopharmacol; 2019 Nov; 76():105872. PubMed ID: 31499268
[TBL] [Abstract][Full Text] [Related]
32. The novel complex combination of alum, CpG ODN and HH2 as adjuvant in cancer vaccine effectively suppresses tumor growth in vivo.
Tian Y; Li M; Yu C; Zhang R; Zhang X; Huang R; Lu L; Yuan F; Fan Y; Zhou B; Men K; Xu H; Yang L
Oncotarget; 2017 Jul; 8(28):45951-45964. PubMed ID: 28515346
[TBL] [Abstract][Full Text] [Related]
33. Tumor-associated antigen/IL-21-transduced dendritic cell vaccines enhance immunity and inhibit immunosuppressive cells in metastatic melanoma.
Aravindaram K; Wang PH; Yin SY; Yang NS
Gene Ther; 2014 May; 21(5):457-67. PubMed ID: 24572790
[TBL] [Abstract][Full Text] [Related]
34. Combination of Photodynamic Therapy and a Flagellin-Adjuvanted Cancer Vaccine Potentiated the Anti-PD-1-Mediated Melanoma Suppression.
Hwang HS; Cherukula K; Bang YJ; Vijayan V; Moon MJ; Thiruppathi J; Puth S; Jeong YY; Park IK; Lee SE; Rhee JH
Cells; 2020 Nov; 9(11):. PubMed ID: 33171765
[TBL] [Abstract][Full Text] [Related]
35. Reduction Sensitive PEG Hydrogels for Codelivery of Antigen and Adjuvant To Induce Potent CTLs.
Kapadia CH; Tian S; Perry JL; Luft JC; DeSimone JM
Mol Pharm; 2016 Oct; 13(10):3381-3394. PubMed ID: 27551741
[TBL] [Abstract][Full Text] [Related]
36. A DNA vaccine targeting p42.3 induces protective antitumor immunity via eliciting cytotoxic CD8+T lymphocytes in a murine melanoma model.
Liu H; Geng S; Feng C; Xie X; Wu B; Chen X; Zou Q; Wang S; Cui J; Xing R; Li W; Lu Y; Wang B
Hum Vaccin Immunother; 2013 Oct; 9(10):2196-202. PubMed ID: 24051432
[TBL] [Abstract][Full Text] [Related]
37. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer.
Wang HL; Xu H; Lu WH; Zhu L; Yu YH; Hong FZ
Arch Gynecol Obstet; 2014 Jan; 289(1):155-62. PubMed ID: 23912529
[TBL] [Abstract][Full Text] [Related]
39. Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.
Saenger YM; Li Y; Chiou KC; Chan B; Rizzuto G; Terzulli SL; Merghoub T; Houghton AN; Wolchok JD
Cancer Res; 2008 Dec; 68(23):9884-91. PubMed ID: 19047169
[TBL] [Abstract][Full Text] [Related]
40. Chronic stress suppresses anti-tumor T
Sommershof A; Scheuermann L; Koerner J; Groettrup M
Brain Behav Immun; 2017 Oct; 65():140-149. PubMed ID: 28457810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
